Basic Bladder Advice and Alarm Therapy in Nocturnal Enuresis
Launched by DALARNA COUNTY COUNCIL, SWEDEN · Jan 18, 2019
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Treatment strategies in nocturnal enuresis
BACKGROUND. Enuresis is the scientific term for bedwetting. Approximately one in ten children in early school age suffers from this condition. Modern research has established three pathogenic mechanisms as crucial:
1. Excessive urine production at night (nocturnal polyuria). The bladder is filled to capacity before the night is over.
2. Nocturnal detrusor overactivity. In these cases, the bladder may contract regardless of whether it is full or not.
3. Almost all children with enuresis are difficult to arouse from sleep and will not wake up when ...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Children 6-11 Years
- • Enuresis (monosymtomatic enuresis)
- Exclusion criteria:
- • Day incontinence (nonmonosymtomatic enuresis)
- • Neurological disease
- • Urological malformation
- • Kidney disease
- • Previous alarm treatment for enuresis
- • Don´t want to stop medication whit Vasopressin (if currant)
About Dalarna County Council, Sweden
Dalarna County Council, based in Sweden, is a public health authority dedicated to enhancing the well-being of its residents through comprehensive healthcare services and innovative research initiatives. As a clinical trial sponsor, Dalarna County Council focuses on advancing medical knowledge and improving patient outcomes by facilitating rigorous clinical studies across various therapeutic areas. Committed to ethical standards and patient safety, the Council collaborates with healthcare professionals, researchers, and academic institutions to foster a dynamic research environment that supports the development of new treatments and healthcare solutions tailored to the needs of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Falun, , Sweden
Patients applied
Trial Officials
Malin Borgström
Study Director
Center for Clinical Research Dalarna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials